Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Envoy Medical (COCH) Operating Expenses (2022 - 2025)

Envoy Medical's Operating Expenses history spans 4 years, with the latest figure at $6.5 million for Q4 2025.

  • Quarterly results put Operating Expenses at $6.5 million for Q4 2025, up 40.71% from a year ago — trailing twelve months through Dec 2025 was $22.5 million (up 15.55% YoY), and the annual figure for FY2025 was $22.5 million, up 15.55%.
  • Operating Expenses for Q4 2025 was $6.5 million at Envoy Medical, up from $5.8 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $6.8 million in Q4 2023 to a low of $901356.0 in Q2 2022.
  • The 4-year median for Operating Expenses is $4.8 million (2024), against an average of $4.2 million.
  • The sharpest move saw Operating Expenses soared 404.02% in 2023, then crashed 32.66% in 2024.
  • Year by year, Operating Expenses stood at $2.9 million in 2022, then soared by 133.01% to $6.8 million in 2023, then crashed by 32.66% to $4.6 million in 2024, then skyrocketed by 40.71% to $6.5 million in 2025.
  • According to Business Quant data, Operating Expenses over the past three periods came in at $6.5 million, $5.8 million, and $5.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.